- Home
- ADAP vs PMVP Comparison
ADAP vs PMVP Comparison
Compare ADAP & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- PMVP
- Stock Information
- Founded
- ADAP 2008
- PMVP 2013
- Country
- ADAP United Kingdom
- PMVP United States
- Employees
- ADAP N/A
- PMVP N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- ADAP Health Care
- PMVP Health Care
- Exchange
- ADAP Nasdaq
- PMVP Nasdaq
- Market Cap
- ADAP 75.5M
- PMVP 71.9M
- IPO Year
- ADAP 2015
- PMVP 2020
- Fundamental
- Price
- ADAP $0.29
- PMVP $0.88
- Analyst Decision
- ADAP Buy
- PMVP Strong Buy
- Analyst Count
- ADAP 6
- PMVP 1
- Target Price
- ADAP $1.52
- PMVP $5.00
- AVG Volume (30 Days)
- ADAP 1.6M
- PMVP 295.9K
- Earning Date
- ADAP 05-13-2025
- PMVP 05-09-2025
- Dividend Yield
- ADAP N/A
- PMVP N/A
- EPS Growth
- ADAP N/A
- PMVP N/A
- EPS
- ADAP N/A
- PMVP N/A
- Revenue
- ADAP $179,639,000.00
- PMVP N/A
- Revenue This Year
- ADAP N/A
- PMVP N/A
- Revenue Next Year
- ADAP $52.49
- PMVP N/A
- P/E Ratio
- ADAP N/A
- PMVP N/A
- Revenue Growth
- ADAP 878.53
- PMVP N/A
- 52 Week Low
- ADAP $0.20
- PMVP $0.81
- 52 Week High
- ADAP $1.48
- PMVP $1.85
- Technical
- Relative Strength Index (RSI)
- ADAP 53.94
- PMVP 39.79
- Support Level
- ADAP $0.26
- PMVP $0.87
- Resistance Level
- ADAP $0.30
- PMVP $0.94
- Average True Range (ATR)
- ADAP 0.03
- PMVP 0.06
- MACD
- ADAP 0.00
- PMVP 0.01
- Stochastic Oscillator
- ADAP 58.12
- PMVP 51.28
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.